BATS BZX Real-Time Price
As of 11:56am ET
| -0.05 / -0.21%|
The 10 analysts offering 12-month price forecasts for Horizon Therapeutics PLC have a median target of 32.50, with a high estimate of 38.00 and a low estimate of 29.00. The median estimate represents a +36.38% increase from the last price of 23.83.
The current consensus among 10 polled investment analysts is to Buy stock in Horizon Therapeutics PLC. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.